Results 71 to 80 of about 359,969 (268)
ABSTRACT Introduction Antimuscarinics, as the current first‐line pharmacologic therapies for overactive bladder, exhibit low patient adherence and high rates of reported side effects. As a modern alternative pharmaceutical treatment, beta‐3 agonists, which relax the urinary bladder, may be more tolerable for patients, increasing adherence and ...
Felicity Smith +2 more
wiley +1 more source
ABSTRACT Purpose To investigate the adenosine receptor (AR) mechanism underlying bladder outlet obstruction (BOO)‐related bladder dysfunction, we examined the expression level of AR subtypes in bladder tissues, and the effects of AR subtypes A2B & A3 modulation on bladder activity using male BOO rats, and Dahl rats with A2B receptor deletion. Materials
Masahiro Kurobe +8 more
wiley +1 more source
Therapeutic options in the treatment of benign prostatic hyperplasia
Jaspreet S SandhuDepartment of Surgery, Division of Urology, Memorial Sloan-Kettering Cancer Center New York, NY 10065, USAAbstract: Current theraputic options for the treatment of symptomatic benign prostatic hyperplasia (BPH) are reviewed.
Jaspreet S Sandhu
core
Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. [PDF]
associated with aging. Thus, the question arises whether or not a correlation exists between the well known prostatic androgen and estrogen accumulation and aging.
Nass, Ralf +3 more
core +2 more sources
Diagnosis of Urethral Resistance in Men: 70 Years of History
ABSTRACT Background and Aims The urethral resistance (UR) is one of the key outcomes of the urodynamic pressure‐flow study (PFS) in men. Combined with a clinical meaningful cut‐off point, urodynamic bladder outflow obstruction (BOO) can be determined. This characterization of BOO provides guidance in the management of lower urinary tract symptoms (LUTS)
Wouter van Dort +2 more
wiley +1 more source
Introduction: Benign prostatic Hyperplasia is a common disorder and cause of morbidity in the ageing men. The evaluation symptoms and the bother associated with it are important for management. International Prostate Symptom Score (IPSS), Quality of life
D Gnyawali, U Sharma
doaj +1 more source
A transition zone enriched WIF1+ basal cell subtype is associated with benign prostatic hyperplasia
Abstract The cellular composition and disease susceptibilities of the distinct zones of the human prostate remain incompletely understood. Benign prostatic hyperplasia (BPH) is a common condition that causes widespread morbidity and is nearly exclusively localized to the transition zone (TZ).
Rulin Wang +20 more
wiley +1 more source
Study of CD117 Expression and Its Relationship with Benign Prostatic Hyperplasia and Gleason Score in Prostatic Adenocarcinoma [PDF]
Background and purpose: Prostate cancer is the second cause of cancer-related death in men. Early diagnosis and identification of prognostic factors help to predict clinical outcome and select the most effective treatment protocol in each patient.
Mehdi Rahmanpour +1 more
doaj
Benign prostatic hyperplasia and periodontitis [PDF]
Benign prostatic hyperplasia and periodontitis are common chronic diseases in middle-aged and elderly people, with many common risk factors and pathogenesis.
HOU Junqing +4 more
core +1 more source
Chronic Pruritic Papular Eruption in an Elderly Man
JEADV Clinical Practice, EarlyView.
Filipe Monteiro +6 more
wiley +1 more source

